Travere Therapeutics, Inc.
(NASDAQ : RTRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 2.98%310.470.0%$5226.27m
BNTXBioNTech SE 3.01%343.540.0%$1578.93m
NVAXNovavax, Inc. -0.83%160.6378.2%$850.44m
AMGNAmgen, Inc. 0.48%202.141.4%$596.10m
GILDGilead Sciences, Inc. -0.24%69.501.0%$508.54m
VRTXVertex Pharmaceuticals, Inc. -0.78%202.861.9%$475.28m
REGNRegeneron Pharmaceuticals, Inc. -1.10%627.012.7%$468.81m
LGVNLongeveron Inc. 17.83%21.210.0%$422.99m
ILMNIllumina, Inc. -3.12%346.333.3%$315.11m
SNSSSunesis Pharmaceuticals, Inc. -2.57%4.170.7%$291.50m
BIIBBiogen, Inc. -2.44%222.951.8%$272.19m
OCGNOcugen, Inc. -9.21%5.730.0%$192.28m
INCYIncyte Corp. -1.46%65.662.4%$153.95m
EXASEXACT Sciences Corp. -5.50%76.1418.0%$147.47m
SGENSeagen Inc. -4.95%150.815.8%$143.89m

Company Profile

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.